• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Increase in prevalence of diabetes mellitus as a cause of dialytic end-stage renal disease: analysis of 20 years in the west region of Paraná].

作者信息

Peres Luis A B, Matsuo Tiemi, Delfino Vinicius D A, Peres Celeide P A, Almeida Netto José Henrique de, Ann Hi K, Camargo Maurício T A, Rohde Noris R S, Uscocovich Vanessa F M

机构信息

Universidade Estadual do Oeste do Paraná.

出版信息

Arq Bras Endocrinol Metabol. 2007 Feb;51(1):111-5. doi: 10.1590/s0004-27302007000100018.

DOI:10.1590/s0004-27302007000100018
PMID:17435864
Abstract

UNLABELLED

Diabetic nephropathy (DN) is the main cause of chronic kidney disease (CKD) in developed countries.

OBJECTIVE

To observe if there was an increase in the prevalence of diabetes mellitus (DM) of CKD in the last 20 years and to analyze comparatively the survival on dialysis of diabetic and non-diabetic patients.

METHODS

Retrospective analysis of patients kept on dialysis in the west region of Paraná State in the period between 1985-2005. Survival analysis was performed using Kaplan-Meier Curves.

RESULTS

In the period, 645 patients were admitted to dialysis. In 16.1% DM was the cause of the CKD. It was observed a progressive increase in the prevalence of DM as a cause of CKD. Patient survival was lower in diabetics.

CONCLUSIONS

The prevalence of DM as a cause of CKD increased in the last 20 years in our region. The survival rates were lower in diabetic than in non-diabetic patients.

摘要

相似文献

1
[Increase in prevalence of diabetes mellitus as a cause of dialytic end-stage renal disease: analysis of 20 years in the west region of Paraná].
Arq Bras Endocrinol Metabol. 2007 Feb;51(1):111-5. doi: 10.1590/s0004-27302007000100018.
2
[Morbidity and mortality in diabetic patients on peritoneal dialysis. Twenty-five years of experience at a single centre].[糖尿病患者腹膜透析的发病率和死亡率。单一中心25年的经验]
Nefrologia. 2010;30(6):626-32. doi: 10.3265/Nefrologia.pre2010.Jul.10553.
3
Renal syndromes in diabetes.
Endocrinol Metab Clin North Am. 1996 Jun;25(2):293-324. doi: 10.1016/s0889-8529(05)70326-1.
4
Epidemiologic analysis of diabetic patients on chronic dialysis.接受长期透析的糖尿病患者的流行病学分析。
Nephron. 1996;74(2):361-6. doi: 10.1159/000189336.
5
End-stage diabetic nephropathy. Discussion: The problem of end-stage diabetic nephropathy.终末期糖尿病肾病。讨论:终末期糖尿病肾病问题。
Kidney Int Suppl. 1974 Oct(1):21-6.
6
5-year overall survival rates of uremic type 1 and type 2 diabetic patients in comparison with age-matched nondiabetic patients with end-stage renal disease from a single dialysis center from 1991 to 1997.1991年至1997年期间,来自单一透析中心的尿毒症1型和2型糖尿病患者与年龄匹配的非糖尿病终末期肾病患者的5年总生存率。
Diabetes Care. 2000 Dec;23(12):1860-2. doi: 10.2337/diacare.23.12.1860.
7
Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry.1980 - 1985年糖尿病肾病患者的肾脏替代治疗。欧洲透析与移植协会登记处报告
Nephrol Dial Transplant. 1988;3(5):585-95. doi: 10.1093/oxfordjournals.ndt.a091710.
8
Non-insulin-dependent diabetes and renal replacement therapy.非胰岛素依赖型糖尿病与肾脏替代治疗
Diabet Med. 1988 Mar;5(2):172-6. doi: 10.1111/j.1464-5491.1988.tb00966.x.
9
[Increasing number of dialysis-requiring patients with diabetic nephropathies. Better diabetes control and antihypertensive treatment can counteract the trend].[需要透析的糖尿病肾病患者数量不断增加。更好地控制糖尿病和进行抗高血压治疗可以抵消这一趋势]
Lakartidningen. 2005;102(18-19):1420-3.
10
Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.终末期肾病患者 2 型糖尿病:对心血管疾病相关死亡率风险的影响。
Med J Aust. 2018 Nov 19;209(10):440-446. doi: 10.5694/mja18.00195. Epub 2018 Oct 22.

引用本文的文献

1
Hsa_circ_0003928 regulates the progression of diabetic nephropathy through miR-136-5p/PAQR3 axis.Hsa_circ_0003928 通过 miR-136-5p/PAQR3 轴调控糖尿病肾病的进展。
J Endocrinol Invest. 2023 Oct;46(10):2103-2114. doi: 10.1007/s40618-023-02061-z. Epub 2023 Apr 5.
2
The Prevalence of Nondiabetic Renal Diseases in Patients with Diabetes Mellitus in the University Hospital of Ribeirão Preto, São Paulo.巴西圣保罗里贝朗普雷图大学医院糖尿病患者中非糖尿病性肾脏疾病的患病率。
J Diabetes Res. 2020 Jun 13;2020:2129459. doi: 10.1155/2020/2129459. eCollection 2020.
3
Evolution of Cardiovascular Diseases Mortality in the Counties of the State of Rio de Janeiro from 1979 to 2010.
1979年至2010年里约热内卢州各县心血管疾病死亡率的演变
Arq Bras Cardiol. 2015 May;104(5):356-65. doi: 10.5935/abc.20150019. Epub 2015 Mar 17.
4
Survival and predictive factors of lethality in hemodialysis: D/I polymorphism of the angiotensin I-converting enzyme and of the angiotensinogen M235T genes.血液透析中致死率的生存及预测因素:血管紧张素I转换酶和血管紧张素原M235T基因的D/I多态性
Arq Bras Cardiol. 2014 Sep;103(3):209-19. doi: 10.5935/abc.20140105. Epub 2014 Jul 29.
5
The ambulatory arterial stiffness index and target-organ damage in Chinese patients with chronic kidney disease.中国慢性肾脏病患者的动态动脉硬化指数与靶器官损害。
BMC Nephrol. 2013 Nov 19;14:257. doi: 10.1186/1471-2369-14-257.